Oxford Science Enterprises
VC🇬🇧 United KingdomInvestment thesis
Independent GBP 850m+ investment company created in 2015 to found, fund and build transformational businesses via a unique partnership with the University of Oxford, under which Oxford is a shareholder and OSE typically receives half the university's equity in a spinout. Focuses on a core portfolio across Life Sciences, HealthTech and Deep Tech.
Notable portfolio
Oxford IonicsAlethio TherapeuticsDark Blue TherapeuticsWild BioscienceOxford Nanopore
Sector focus
Life sciencesHealthDeep TechQuantumAIFusionRoboticsBiotech